A Korean company where most of its employees earn 800 million in one day.

SK Bioscience’s’Tasang’ success

Employees, earn 800 million in one day

SK Bioscience (SK Basa), referred to as the’second SK Biopharm’, succeeded in’Tasang’ on the first day of listing on the stock market (KOSPI). Employees who received our stock stock attracted attention with a profit of nearly 800 million won in one day.

On the 18th, SK Bioscience started trading at 130,000 won, which doubles the public offering price (65,000 won) at 9 am, and immediately rises to the price limit, recording 169,000 won as of 1:40 pm.

According to Newsis, SK Basa allotted 4.45 million shares, which is 19.57% of the total allocation, to employee stock ownership in this subscription, and the number of shares subscribed by members of employee stock ownership is 4.94 million.

The total number of employees at SK Basa is 827 (including 236 people on a fixed-term basis). Among them, the media reported that there were about 600 members who actually participated in the subscription to our stock shares.

The average number of shares allocated per person was 7484, and the valuation gain per person was averaged about 778 million won.

Like SK Biopharm, if you go to’Dad Sangsang’, the valuation profit per person jumps to 1.65 billion won.

Employee stock ownership stocks cannot be sold for one year after listing. Selling is possible only after leaving the company. In the case of SK Biopharm, which was listed last year, some employees left the company to realize the profits of the company’s own stockholders.

The executives also got a big hit. Newsys reported that executives earned a stock option valuation gain of 17.5 billion to 34.9 billion won.